Alemtuzumab improves contrast sensitivity in patients with relapsing-remitting multiple sclerosis. Graves J, Galetta SL, Palmer J, Margolin DH, Rizzo M, Bilbruck J, Balcer LJ Mult Scler. 2013 Mar 4. PMID: 23459567. Abstract CommentRecommendBookmarkWatch